scorecardresearch
Add as a preferred source on Google
Tuesday, April 7, 2026
TopicAdar Poonawalla

Topic: Adar Poonawalla

What Poonawalla’s Rs 1,000 crore deal means for Dharma—more freedom, big-budget productions

Karan Johar recently spoke about exorbitant star fees and rising entourage costs, which were affecting the industry and production of films.

Karan Johar’s studio sells 50% stake worth 10 bn rupees to vaccine maker Adar Poonawalla

SII CEO will buy stake through his production company, Serene Productions -- another major investment outside pharma sector after picking up 20% of social media platform Wakau Interactive in 2021.

A piece of bone, hair sent for advanced DNA test belong to Shraddha Walkar, say police

A superior mitochondrial DNA test is run when nuclear DNA cannot be extracted from samples or when they are highly decomposed.

ThePrint’s Editor-in-Chief Shekhar Gupta recognised with ‘Lifetime Contribution to Media’ award

Thirteen other noted personalities including Serum Institute of India CEO Adar Poonawalla and Tata Sons Chairman N Chandrasekaran were also awarded under various categories by AIMA.

Didn’t suit global narrative that Indian firm could deliver quality, says SII’s Poonawalla

CEO of world’s largest vaccine maker says India is better equipped to deal with pandemics now, adds a global treaty is important to allow resource-sharing across borders.

Modi on Time 100 list for ‘Hindu nationalism, eroding Muslims’ rights, mishandling Covid’

Modi is one of three Indians on Time’s 100 Most Influential list. The only other Indian politician on the list is West Bengal Chief Minister Mamata Banerjee.

Biocon partners SII to make vaccine, drug manufacturing accessible to developing nations

Under the deal, Biocon Biologics Ltd (BBL) will offer approximately 15% stake to Serum Institute Life Sciences at a post-money valuation of about Rs 35,000 crore.

‘Taken this up at highest levels’, Poonawalla assures India as EU Green Pass excludes Covishield

EU's Green Pass, which will be available for use from July 1, includes 4 vaccines approved by the European Medicines Agency.

On Camera

Syringes, MRI to ventilators, West Asia war squeezing India’s medical supply chain—costs up 10 to 50%

Industry says manufacturers have 2-4 weeks of buffer stocks, but prolonged disruption could push up shortage risks, especially of consumables like IV and syringes.

UAE walks away from financing Rafale F5 due to restricted access to technology, reports French media

French newspaper La Tribune earlier last week indicated that UAE withdrew from deal to fund EUR 3.5 billion. India is looking to order 114 new Rafales, which could include the F5.

China insulated itself against energy shocks. India is ‘all talk, no walk’

China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.